Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Metastatic Castration-resistant Prostate Cancer”

606 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 606 results

Large-scale testing (Phase 3)UnknownNCT01949337
What this trial is testing

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Alliance for Clinical Trials in Oncology 1,311
Not applicableUnknownNCT05078151
What this trial is testing

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Vall d'Hebron Institute of Oncology 69
Not applicableLooking for participantsNCT06031805
What this trial is testing

PRostate Olaparib Real World Evidence Study

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
AstraZeneca 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT06909825
What this trial is testing

FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Fusion Pharmaceuticals Inc. 85
Early research (Phase 1)Study completedNCT01792687
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

Who this might be right for
Prostate Cancer
Aragon Pharmaceuticals, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT06972628
What this trial is testing

Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

Who this might be right for
Metastatic Castration-Resistant Prostate CancerProstate Cancer Patients With Bone MetastasisProstate Cancer (CRPC)+2 more
Ebrahim S Delpassand 30
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Testing effectiveness (Phase 2)Ended earlyNCT01267266
What this trial is testing

Saracatinib in Treating Patients With Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT01942837
What this trial is testing

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 67
Early research (Phase 1)Study completedNCT00302471
What this trial is testing

MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)

Who this might be right for
Prostatic Neoplasms
Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)Study completedNCT01468532
What this trial is testing

Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 18
Not applicableStudy completedNCT03563014
What this trial is testing

A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bayer 164
Early research (Phase 1)Looking for participantsNCT05806814
What this trial is testing

Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
University of Oklahoma 13
Testing effectiveness (Phase 2)Ended earlyNCT03741712
What this trial is testing

SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC

Who this might be right for
Prostate CancerCastration-resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT01591122
What this trial is testing

Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 313
Not applicableActive Not RecruitingNCT04024475
What this trial is testing

Prostate Cancer Biobank

Who this might be right for
Prostatic Neoplasms
Swiss Cancer Institute 1,323
Early research (Phase 1)Study completedNCT01162395
What this trial is testing

Open Label Prostate Cancer Study

Who this might be right for
Prostate Cancer
AstraZeneca 64
Testing effectiveness (Phase 2)Study completedNCT02598895
What this trial is testing

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
University of Washington 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05682443
What this trial is testing

ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
OncoC4, Inc. 148
Not applicableStudy completedNCT03075735
What this trial is testing

Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)

Who this might be right for
Prostate Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 408
Load More Results